Jean-Michel Boers has been responsible for the U.S. Human Pharma business since January 2017 as President of Boehringer Ingelheim Pharmaceuticals, Inc. In his role, he has steered the successful growth and development of the company’s primary and specialty care portfolio, while positioning the organization for future indication and product launches in areas of unmet medical need

After starting his career with a German management consulting firm, Mr. Boers joined Boehringer Ingelheim in 1998 and advanced through diverse international leadership roles, including Corporate Vice President of Marketing and Sales Effectiveness at the global headquarters in Ingelheim Germany, Country Managing Director in France and Head of Human Pharma for a newly formed European regional operating unit. In July 2016, he moved to the US initially heading the Specialty Care franchise before taking leadership of the Human Pharma business in 2017.

Mr. Boers has been appointed as the U.S. Country Managing Director, President and CEO effective August 1, 2020.

Mr. Boers earned an M.A. in Social and Economic History from the University of Nijmegen (Netherlands) and an M.B.A. from the University of Texas.

A citizen of both France and the Netherlands, Jean-Michel lives with his wife Sabine and two of their three sons.